Modern approaches to the management of pregnant patients with fetal growth restriction
https://doi.org/10.51523/2708-6011.2025-22-1-01
Abstract
An analytical review of literature data on modern approaches to the management of pregnant patients with fetal growth restriction (FGR) was carried out, which revealed the main problems relating to terminology, diagnosis, treatment, prevention and delivery of patients with this pathology. Data from literary sources are illustrated by personal observations, which showed that FGR remains a complex problem of obstetrics and requires a high degree of professional competence and ethical responsibility when choosing tactics for pregnancy management. According to the conducted study, it was concluded that it is necessary to introduce international approaches to the problem of FGR into the clinical practice of obstetricians and gynecologists of the Republic of Belarus.
Keywords
About the Authors
E. A. EinyshBelarus
Elena A. Einysh - Candidate of Medical Sciences, Associate Professor at the Department of Obstetrics and Gynecology with the course of Advanced Training and Retraining.
Gomel
Yu. A. Lyzikova
Belarus
Yuliya A. Lyzikova, Doctor of Medical Sciences, Associate Professor, Professor at the Department of Obstetrics and Gynecology with the course of Advanced Training and Retraining.
Gomel
A. N. Bodruseva
Belarus
Anna N. Bodruseva - General Practitioner of the Perinatal Center.
Gomel
N. V. Krautsova
Belarus
Natalyia V. Krautsova - Head of the Pathologic Pregnancy Department.
Gomel
T. A. Kiselyova
Belarus
Tatyana A. Kiselyova - Head of the Observation Department No2.
Gomel
References
1. Blue NR, Page JM, Silver RM. Recurrence Risk of Fetal Growth Restriction: Management of Subsequent Pregnancies. Obstet Gynecol Clin North Am. 2021 Jun;48(2):419-436. DOI: https://doi.org/10.1016/j.ogc.2021.03.002
2. Clinical guidelines approved by the Russian Ministry of Health. Obstetrics. [date of access 2024 May 27]. Available from: https://roag-portal.ru/recommendations_obstetrics (In Russ.).
3. Dobrokhotova YE, Kuznetsov PA, Dzhokhadze LS, Shamugia VV, Kravtsova OM. Insufficient fetal growth: fetal growth restriction or small for gestational age fetus? The difference between these conditions, what is known about diagnosis, prevention and treatment: A review. Gynecology. 2022;24(1):24-29. (In Russ.). DOI: https://doi.org/10.26442/20795696.2022.1.201360
4. Westby A, Miller L. Fetal Growth Restriction Before and After Birth. Am Fam Physician. 2021;104(5):486-492.
5. Mustafa HJ, Javinani A, Muralidharan V, Khalil A. Diagnostic performance of 32 vs 36 weeks ultrasound in predicting late-onset fetal growth restriction and small-for-gestational-age neonates: a systematic review and meta-analysis. Am J Obstet Gynecol MFM. 2024 Jan;6(1):101246. DOI: https://doi.org/10.1016/j.ajogmf.2023.101246
6. Powel JE, Chavan NR, Zantow EW, Bialko MF, Farley LG, McCormick KM, et al. Risk of adverse perinatal outcomes in pregnancies with “small” fetuses not meeting Delphi consensus criteria for fetal growth restriction. Am J Obstet Gynecol. 2023 Oct;229(4):447.e1-447.e13. DOI: https://doi.org/10.1016/j.ajog.2023.04.037
7. Giouleka S, Tsakiridis I, Mamopoulos A, Kalogiannidis I, Athanasiadis A, Dagklis T. Fetal Growth Restriction: A Comprehensive Review of Major Guidelines. Obstet Gynecol Surv. 2023 Nov;78(11):690-708. DOI: https://doi.org/10.1097/OGX.0000000000001203
8. Alameddine S, Capannolo G, Rizzo G, Khalil A, Di Girolamo R, Iacovella C, et al. A systematic review and critical evaluation of quality of clinical practice guidelines on fetal growth restriction. J Perinat Med. 2023 Mar 29;51(8):970-980. DOI: https://doi.org/10.1515/jpm-2022-0590
9. Melamed N, Baschat A, Yinon Y, Athanasiadis A, Mecacci F, Figueras F, et al. FIGO (international Federation of Gynecology and obstetrics) initiative on fetal growth: best practice advice for screening, diagnosis, and management of fetal growth restriction. Int J Gynaecol Obstet. 2021 Mar;152 Suppl 1(Suppl 1):3-57. DOI: https://doi.org/10.1002/ijgo.13522
10. Beune IM, Damhuis SE, Ganzevoort W, Hutchinson JC, Khong TY, Mooney EE, et al. Consensus Definition of Fetal Growth Restriction in Intrauterine Fetal Death: A Delphi Procedure. Arch Pathol Lab Med. 2021 Apr 1;145(4):428-436. DOI: https://doi.org/10.5858/arpa.2020-0027-OA
11. Kingdom J, Ashwal E, Lausman A, Liauw J, Soliman N, Figueiro-Filho, et al. Guideline No. 442: Fetal Growth Restriction: Screening, Diagnosis, and Management in Singleton Pregnancies. J Obstet Gynaecol Can. 2023 Oct;45(10):102154. DOI: https://doi.org/10.1016/j.jogc.2023.05.022
12. R.S. Osipov, P.A. Kuznetsov, L.S. Dzhokhadze, I.O. Shuginin. What’s new in the prevention and therapy of fetal growth restriction? Role of nitric oxide RMJ. Mother and child. 2023;6(3):258-264. (In Russ.). DOI: https://doi.org/10.32364/2618-8430-2023-6-3-7
13. Mascherpa M, Pegoire C, Meroni A, Minopoli M, Thilaganathan B, Frick A, et al. Prenatal prediction of adverse outcome using different charts and definitions of fetal growth restriction. Ultrasound Obstet Gynecol. 2024 May;63(5):605-612. DOI: https://doi.org/10.1002/uog.27568
14. Powel JE, Chavan NR, Tomlinson TM. Fetal growth restriction or small for gestational age? Consideration of biometry alone and criteria performance. Am J Obstet Gynecol. 2023 Nov;229(5):571-572. DOI: https://doi.org/10.1016/j.ajog.2023.06.005
15. Powel JE, Chavan NR, Zantow EW, Bialko MF, Farley LG, McCormick KM, et al. Risk of adverse perinatal outcomes in pregnancies with “small” fetuses not meeting Delphi consensus criteria for fetal growth restriction. Am J Obstet Gynecol. 2023 Oct;229(4):447.e1-447.e13. DOI: https://doi.org/10.1016/j.ajog.2023.04.037
16. Schlembach D. Fetal Growth Restriction - Diagnostic Work-up, Management and Delivery. Geburtshilfe Frauenheilkd. 2020 Oct;80(10):1016-1025. DOI: https://doi.org/10.1055/a-1232-1418
17. Hoyer D, Schmidt A, Pytlik A, Viehöfer L, Gonçalves H, Amorim-Costa C, et al. Can fetal heart rate variability obtained from cardiotocography provide the same diagnostic value like from electrophysiological interbeat intervals? Physiol Meas. 2021 Feb 11;42(1):015006. DOI: https://doi.org/10.1088/1361-6579/abc791
18. Starodubtseva NL, Tokareva AO, Volochaeva MV, Kononikhin AS, Brzhozovskiy AG, Bugrova AE, et al. Quantitative Proteomics of Maternal Blood Plasma in Isolated Intrauterine Growth Restriction. Int J Mol Sci. 2023 Nov 27;24(23):16832. DOI: https://doi.org/10.3390/ijms242316832
19. Bahado-Singh, R., Turkoglu, O., Yilmaz, A., Kumar, P., Zeb, A., Konda, S., et al. Metabolomic identification of placental alterations in fetal growth restriction. The Journal of Maternal-Fetal & Neonatal Medicine. 2020;35:447-456. DOI: https://doi.org/10.1080/14767058.2020.1722632
20. Yang J, Liu Y, Dong M. Integrated Bioinformatics Analysis to Screen Hub Gene Signatures for Fetal Growth Restriction. Genet Res (Camb). 2023 Mar 30;2023:3367406. DOI: https://doi.org/10.1155/2023/3367406
21. Volochaeva MV, Tokareva AO, Kononikhin AS, Kukaev EN, Tyutyunnik VL, Kan NE, et al. Diagnostic significance of proteome analysis of maternal plasma in fetal growth restriction. Obstetrics and Gynecology. 2024;(4):59-68. (In Russ.). DOI: https://doi.org/10.18565/aig.2023.299
22. Eroğlu H, Tonyalı NV, Orgul G, Biriken D, Yucel A, Yazihan N, Uygur D. Is ProBNP a New Marker for Predicting Intrauterine Growth Restriction? Z Geburtshilfe Neonatol. 2021 Apr;225(2):125-128. DOI: https://doi.org/10.1055/a-1382-8787
23. Rolnik DL, Nicolaides KH, Poon LC. Prevention of preeclampsia with aspirin. Am J Obstet Gynecol. 2022 Feb;226(2S):S1108-S1119. DOI: https://doi.org/10.1016/j.ajog.2020.08.045
24. D’Antonio F, Khalil A, Rizzo G, Fichera A, Herrera M, Buca D, et al. Aspirin for prevention of preeclampsia and adverse perinatal outcome in twin pregnancies: a systematic review and meta-analysis. Am J Obstet Gynecol MFM. 2023 Feb;5(2):100803. DOI: https://doi.org/10.1016/j.ajogmf.2022.100803
25. Hamulyák EN, Scheres LJ, Marijnen MC, Goddijn M, Middeldorp S. Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss. Cochrane Database Syst Rev. 2020 May 2;5(5):CD012852. DOI: https://doi.org/10.1002/14651858.CD012852.pub2
26. Massimiani M, Tiralongo GM, Salvi S, Fruci S, Lacconi V, La Civita F, et al. Treatment of pregnancies complicated by intrauterine growth restriction with nitric oxide donors increases placental expression of Epidermal Growth Factor-Like Domain 7 and improves fetal growth: A pilot study. Transl Res. 2021 Feb;228:28-41. DOI: https://doi.org/10.1016/j.trsl.2020.08.002
27. Rakhanova Y, Almawi WY, Aimagambetova G, Riethmacher D. The effects of sildenafil citrate on intrauterine growth restriction: a systematic review and meta-analysis. BMC Pregnancy Childbirth. 2023 Jun 2;23(1):409. DOI: https://doi.org/10.1186/s12884-023-05747-7
28. Kitase Y, Sato Y, Arai S, Onoda A, Ueda K, Go S, et al. Establishment of a Novel Fetal Growth Restriction Model and Development of a Stem-Cell Therapy Using Umbilical Cord-Derived Mesenchymal Stromal Cells. Front Cell Neurosci. 2020 Jul 28;14:212. DOI: https://doi.org/10.3389/fncel.2020.00212
29. Wilson RL, Lampe K, Gupta MK, Duvall CL, Jones HN. Nanoparticle-mediated transgene expression of insulin-like growth factor 1 in the growth restricted guinea pig placenta increases placenta nutrient transporter expression and fetal glucose concentrations. Mol Reprod Dev. 2022 Nov;89(11):540-553. DOI: https://doi.org/10.1002/mrd.23644
30. Kinoshita M, Crispi F, Loreiro C, Gratacós E, Illa M, Zamora M. Strategies for intra-amniotic administration of fetal therapy in a rabbit model of intrauterine growth restriction. Experimental Biology and Medicine. 2021;246:1668-1679. DOI: https://doi.org/10.1177/15353702211003508
31. Sacchi C, Marino C, Nosarti C, Vieno A, Visentin S, Simonelli A. Association of Intrauterine Growth Restriction and Small for Gestational Age Status with Childhood Cognitive Outcomes: A Systematic Review and Meta-analysis. JAMA Pediatr. 2020 Aug 1;174(8):772-781. DOI: https://doi.org/10.1001/jamapediatrics.2020.1097
Review
For citations:
Einysh E.A., Lyzikova Yu.A., Bodruseva A.N., Krautsova N.V., Kiselyova T.A. Modern approaches to the management of pregnant patients with fetal growth restriction. Health and Ecology Issues. 2025;22(1):7-14. (In Russ.) https://doi.org/10.51523/2708-6011.2025-22-1-01